1005486-45-2

Upstream product

• 160835-80-3 methyl 2,3,4-tri-O-benzyl-4-C-methyl-α-D-glucopyranoside 

Downstream Products

• 1005486-46-3 methyl 2,3,4-tri-O-benzyl-4-C-methyl-7-deoxy-L-glycero-α-D-gluco-heptapyranoside 
• 1005486-47-4 methyl 2,3,4-tri-O-benzyl-4-C-methyl-7-deoxy-D-glycero-α-D-gluco-heptapyranoside 

Relevant academic research and scientific papers

BENZYL PHENYL GLUCOPYRANOSIDE DERIVATIVE

The present invention relates to a benzylphenyl glucopyranoside derivative having an excellent inhibitory effect on human SGLT1 and/or SGLT2 activity. There is provided a compound or a pharmacologically acceptable salt thereof represented by the following general formula (I): wherein R1 represents a hydrogen atom, an amino group, a hydroxy C1-C6 alkyl group, etc.; R2 represents a hydrogen atom, etc.; R3 represents a C1-C6 alkyl group, a hydroxy C1-C6 alkyl group, etc.; R4 represents a hydrogen atom, a C2-C7 acyl group, etc.; R5, R6, R7, and R8 are the same or different and each represents a hydrogen atom or a C1-C6 alkyl group, provided that R5, R6, R7 and R8 are not hydrogen atoms at the same time; n is 0 to 4; and X is CH or N.